Developmental toxicity, antioxidant, and marker enzyme assessment of swertiamarin in zebrafish (Danio rerio)

A secoiridoid glycoside called swertiamarin has been widely used as a herbal medicine for many decades. In particular, swertiamarin from the Enicostema axillare herb has been used as a multipurpose drug to treat innumerable health problems. As this medicine is consumed orally, its toxicity level should be determined. To examine the safety of this compound, toxicology work was done in zebrafish, and this is the first report to describe swertiamarin toxicity in zebrafish. Zebrafish embryos were used in this swertiamarin toxicity study, and morphological changes were observed. Further, the compound was also studied in adult zebrafish to determine the impact of the compound on the fish liver. Enzyme profiling with superoxide dismutase, glutathione peroxidase, catalase, reduced glutathione levels, glutathione S-transferase, lactate dehydrogenase, glutamic oxaloacetic transaminases, lipid peroxidation, Na+/K+-ATPase, and glutamic pyruvic transaminases) was evaluated (p <= 0.05). Results suggest that swertiamarin is a safe drug only at a low concentration (40 mu M). This study also shows that even herbal medicinal compounds may be toxic to humans at higher dosages. Hence, irrespective of whether a drug is synthetic or natural, it needs to be tested for its toxicity before use in humans.

Automated summary

Swertiamarin, a secoiridoid glycoside used as a herbal medicine, was found to be safe in zebrafish at a low concentration but potentially toxic to humans at higher doses. Toxicology work was done in zebrafish to examine the compound's safety, highlighting the importance of testing both synthetic and natural drugs for toxicity before human use.